Table A1.
Prescriptions of glucose-lowering drugs (90 patients).
| Label | Number of Prescribed Medications (n = 151) | Average Daily Dosage |
|---|---|---|
| Insulins and analogs | 53 (35.1%) | IU |
| Rapid-acting injectable insulins and analogs | 14 (9.3%) | |
| Insulins and analogs with intermediate or long-acting action and rapid onset of action by injection | 1 (0.7%) | |
| Long-acting injectable insulins and analogs | 38 (25.2%) | |
| Insulin glargine | 28 | 20.0 |
| Insulin detemir | 10 | 21.5 |
| Glucose-lowering drugs other than insulins | mg | |
| Biguanide | 50 (33.1%) | 1739.0 |
| Sulfonylurea drugs | 13 (8.6%) | |
| Glibenclamide | 1 | 7.5 |
| Gliclazide | 9 | 85.6 |
| Glimepiride | 3 | 1.7 |
| Alpha glucosidase inhibitors | 3 (2.0%) | 150.0 |
| Dipeptidyl Peptidase 4 (DPP-4) inhibitors | 19 (12.6%) | |
| Sitagliptin | 15 | 96.4 |
| Vildagliptin | 4 | 75.0 |
| Glucagon-Like-Peptide-1 (GLP-1) Analogs | 2 (1.3%) | |
| Liraglutide | 2 | 1.5 |
| Repaglinide | 11 | 2.6 |